The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-04-10
著者
-
GUAY David
Feldan Bio Inc.
-
LEBEL Michel
Department of Molecular Biology, Medical Biochemistry, and Pathology, Laval University Quebec City
-
Lebel Michel
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
Garand Chantal
Department Of Molecular Biology Medical Biochemistry And Pathology Laval University Quebec City
-
GUAY David
Centre de Recherche en Cancerologie de l'Universite Laval, Hopital Hotel-Dieu de Quebec
-
GARAND Chantal
Centre de Recherche en Cancerologie de l'Universite Laval, Hopital Hotel-Dieu de Quebec
-
REDDY Shanti
Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University
-
SCHMUTTE Chris
Department of Molecular Virology, Immunology and Medical Genetics, Ohio State University
-
LEBEL Michel
Centre de Recherche en Cancerologie de l'Universite Laval, Hopital Hotel-Dieu de Quebec
-
Schmutte Chris
Department Of Molecular Virology Immunology And Medical Genetics Ohio State University
-
Reddy Shanti
Department Of Molecular Virology Immunology And Medical Genetics Ohio State University
関連論文
- An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells
- The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells